Sanofi Balance Sheet Health
Financial Health criteria checks 6/6
Sanofi has a total shareholder equity of €73.0B and total debt of €23.8B, which brings its debt-to-equity ratio to 32.5%. Its total assets and total liabilities are €129.8B and €56.8B respectively. Sanofi's EBIT is €9.0B making its interest coverage ratio 56.4. It has cash and short-term investments of €6.8B.
Key information
32.5%
Debt to equity ratio
€23.75b
Debt
Interest coverage ratio | 56.4x |
Cash | €6.80b |
Equity | €73.00b |
Total liabilities | €56.76b |
Total assets | €129.76b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SNW2's short term assets (€30.1B) exceed its short term liabilities (€30.0B).
Long Term Liabilities: SNW2's short term assets (€30.1B) exceed its long term liabilities (€26.7B).
Debt to Equity History and Analysis
Debt Level: SNW2's net debt to equity ratio (23.2%) is considered satisfactory.
Reducing Debt: SNW2's debt to equity ratio has reduced from 47.2% to 32.5% over the past 5 years.
Debt Coverage: SNW2's debt is well covered by operating cash flow (34.2%).
Interest Coverage: SNW2's interest payments on its debt are well covered by EBIT (56.4x coverage).